Research Article
Caffeamide 36-13 Regulates the Antidiabetic and Hypolipidemic Signs of High-Fat-Fed Mice on Glucose Transporter 4, AMPK Phosphorylation, and Regulated Hepatic Glucose Production
Table 2
Effects of caffeamide 36-13 (TS) on absolute tissue weight, food intake, liver lipids and blood profiles.
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
All values are means ± S.E. (). , , compared with the control (CON) group; , , compared with the high-fat + vehicle (distilled water) (HF) group. TS: T1: 0.01, T2: 0.02 g/kg bodyweight; Rosi: rosiglitazone (0.01 g/kg body weight). BAT, brown adipose tissue; RWAT, retroperioneal white adipose tissue; MWAT, mesenteric white adipose tissue; FFA, plasma free fatty acid; TC, total cholesterol; TG, triglyceride. aDose (g/kg/day). |